22157.jpg
Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
May 17, 2023 05:23 ET | Research and Markets
Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key...
22157.jpg
Outlook on the Prosthetic Heart Valve Global Market to 2028 - Rising Prevalence of Cardiovascular Diseases is Driving Growth
August 19, 2022 06:03 ET | Research and Markets
Dublin, Aug. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Prosthetic Heart Valve Market Size, Share & Industry Trends Analysis Report By End User (Hospitals & Cardiac Centers and Ambulatory...
Global Transcatheter Heart Valve Replacement Market
Global Transcatheter Heart Valve Replacement Market (2022 to 2027) - Featuring Edwards Lifesciences, Abbott Laboratories and Medtronic Among Others
February 14, 2022 04:33 ET | Research and Markets
Dublin, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The "Transcatheter Heart Valve Replacement Market, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" report has...
22157.jpg
Global Structural Heart Devices Market Report 2021: Analysis of Key Competitors by Segments, Mergers and Acquisitions, and Emerging Start-ups
November 16, 2021 09:53 ET | Research and Markets
Dublin, Nov. 16, 2021 (GLOBE NEWSWIRE) -- The "Global Structural Heart Devices Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. Even though structural heart...
22157.jpg
Global Transcatheter Heart Valve Replacement Devices Market Report 2021 Featuring Edwards Lifesciences, Medtronic, Livanova, Abbott, Boston Scientific, CryoLife
September 03, 2021 04:03 ET | Research and Markets
Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "Transcatheter Heart Valve Replacement Devices - Market Insights, Competitive Landscape and Market Forecast - 2026" drug pipelines has been added to...
22157.jpg
Global Prosthetic Heart Valve Devices and Equipment Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
August 30, 2021 06:58 ET | Research and Markets
Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The "Prosthetic Heart Valve Devices and Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to...
22157.jpg
Global Transcatheter Treatment: Procedures and Heart Valve Market (2020 to 2025) - Featuring Biotronik, Boston Scientific and Bracco Among Others
February 11, 2021 07:38 ET | Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Transcatheter Treatment: Procedures and Heart Valve Market" report has been added to ResearchAndMarkets.com's offering. Transcatheter treatment...
Neovasc_Logo-web-header.jpg
Neovasc Has Filed for CE Mark for Tiara TA Transapical Mitral Valve Replacement System
May 27, 2020 09:42 ET | Neovasc, Inc.
Less invasive approach provides hope for the millions of patients that suffer from leaky mitral valves VANCOUVER and MINNEAPOLIS, MN, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
Neovasc_Logo-web-header.jpg
Neovasc Announces Notice of US Patent Granted for Tiara™ Transcatheter Device for Treatment of Severe Mitral Regurgitation
October 15, 2019 07:00 ET | Neovasc, Inc.
VANCOUVER, Oct. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
Minimally Invasive Investigational Procedure Treats Mitral Regurgitation as an Alternative to Open Heart Surgery
April 25, 2018 13:00 ET | UPMC Pinnacle
HARRISBURG, PA, April 25, 2018 (GLOBE NEWSWIRE) -- The ACTIVE trial studies Edwards Cardioband Mitral Reconstruction System, a catheter-based annular reduction device for treatment of functional...